Evidence map›Paper›PMID 41393718›Full record

ArticleCureus2025

Toe Necrosis: A Surprising Herald of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Anil Regmi, Payal Shukla, Pragya Karki, Deya Obaidat

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anil RegmiInternal Medicine, Parkview Health, Fort Wayne, USA.
Payal ShuklaInternal Medicine, Parkview Health, Fort Wayne, USA.
Pragya KarkiInternal Medicine, Nepalese Army Institute of Health Sciences, Kathmandu, NPL.
Deya ObaidatRheumatology, Parkview Health, Fort Wayne, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic vasculitides can affect any type of blood vessel and can present with various signs and symptoms depending on the site and type of affected blood vessels. The antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) can affect small- to medium-sized vessels. It can involve various organs and present with varying clinical and pathological features. Although rare, it can affect the blood vessels of the toes, leading to distal ischemia and gangrene. A 74-year-old woman with multiple comorbidities presented with symptoms of chronic nasal congestion, joint pain, and neuropathy, prompting autoimmune evaluation. Due to positive antinuclear antibody and perinuclear ANCA titer, initial treatment with low-dose prednisone and methotrexate was introduced. However, later during the course, she developed bilateral toe necrosis despite being on treatment. The workup for neurological and cardiovascular causes for the toe necrosis was negative. The patient ultimately required bilateral metatarsal amputation. Post-surgery, she was treated with rituximab and prednisone, which resulted in improvement in vasculitis. This case highlights the importance of recognizing rare presentations of AAV to enable timely intervention and prevent severe complications.

Indexed as

ancamyeloperoxidase antibodyrituximabtoe necrosisvasculitis

Identifiers

PMID41393718
PMCPMC12697005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.